MedKoo Cat#: 128631 | Name: Protamine sulfate
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Protamine sulfate is a transduction efficiency enhancer, also apelin receptor antagonist.

Chemical Structure

Protamine sulfate
Protamine sulfate
CAS#53597-25-4

Theoretical Analysis

MedKoo Cat#: 128631

Name: Protamine sulfate

CAS#: 53597-25-4

Chemical Formula: C17H22N4O4

Exact Mass: 346.1641

Molecular Weight: 346.39

Elemental Analysis: C, 58.95; H, 6.40; N, 16.17; O, 18.48

Price and Availability

Size Price Availability Quantity
10mg USD 350.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Protamine sulfate; Protamine;
IUPAC/Chemical Name
1-(3-(hydroxymethyl)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-7-yl)-3-(1-phenylethyl)urea
InChi Key
AGGKBDWGEXEBOT-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H22N4O4/c1-10(11-5-3-2-4-6-11)18-17(25)19-12-7-14-15(23)20-13(9-22)16(24)21(14)8-12/h2-6,10,12-14,22H,7-9H2,1H3,(H,20,23)(H2,18,19,25)
SMILES Code
CC(C1=CC=CC=C1)NC(=O)NC2CC3C(=O)NC(C(=O)N3C2)CO
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 346.39 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Boer C, Meesters MI, Veerhoek D, Vonk ABA. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. Br J Anaesth. 2018 May;120(5):914-927. doi: 10.1016/j.bja.2018.01.023. Epub 2018 Feb 26. PMID: 29661409. 2: Jodar M, Oliva R. Protamine alterations in human spermatozoa. Adv Exp Med Biol. 2014;791:83-102. doi: 10.1007/978-1-4614-7783-9_6. PMID: 23955674. 3: Horrow JC. Protamine: a review of its toxicity. Anesth Analg. 1985 Mar;64(3):348-61. PMID: 3883848. 4: McMillan RB, Bediako H, Devenica LM, Velasquez A, Hardy IP, Ma YE, Roscoe DM, Carter AR. Protamine folds DNA into flowers and loop stacks. Biophys J. 2023 Nov 7;122(21):4288-4302. doi: 10.1016/j.bpj.2023.10.003. Epub 2023 Oct 6. PMID: 37803830; PMCID: PMC10645571. 5: Ukogu OA, Smith AD, Devenica LM, Bediako H, McMillan RB, Ma Y, Balaji A, Schwab RD, Anwar S, Dasgupta M, Carter AR. Protamine loops DNA in multiple steps. Nucleic Acids Res. 2020 Jun 19;48(11):6108-6119. doi: 10.1093/nar/gkaa365. PMID: 32392345; PMCID: PMC7293030. 6: Vandenheuvel M, Vandewiele K, De Somer F, Wouters PF. Protamine dosing in cardiac surgery. Perfusion. 2024 Apr;39(3):645-646. doi: 10.1177/02676591231154116. Epub 2023 Jan 25. PMID: 36696481. 7: Mukherjee A, de Izarra A, Degrouard J, Olive E, Maiti PK, Jang YH, Lansac Y. Protamine-Controlled Reversible DNA Packaging: A Molecular Glue. ACS Nano. 2021 Aug 24;15(8):13094-13104. doi: 10.1021/acsnano.1c02337. Epub 2021 Jul 30. PMID: 34328301. 8: Lapage K, Ongena M, Poelaert J. Protamine Dose Reduction: the European versus US View. J Cardiothorac Vasc Anesth. 2023 Oct;37(10):2159-2160. doi: 10.1053/j.jvca.2023.06.030. Epub 2023 Jun 20. PMID: 37479640. 9: Hecht P, Besser M, Falter F. Are We Able to Dose Protamine Accurately Yet? A Review of the Protamine Conundrum. J Extra Corpor Technol. 2020 Mar;52(1):63-70. doi: 10.1182/ject-1900038. PMID: 32280146; PMCID: PMC7138116. 10: Hall RI. Protamine dosing--the quandary continues. Can J Anaesth. 1998 Jan;45(1):1-5. English, French. doi: 10.1007/BF03011983. PMID: 9466018.